On November 15, 2024, Paul Bolno, President and Chief Executive Officer of WAVE Life Sciences Ltd (WVE, Financial), sold 51,234 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 217,351 shares of WAVE Life Sciences Ltd.
WAVE Life Sciences Ltd is a biotechnology firm focused on delivering transformational therapies for patients with serious, genetically-defined diseases. The company's innovative approach harnesses proprietary chemistry platforms to design, develop, and commercialize complex molecules as potential treatments.
Over the past year, the insider has sold a total of 190,074 shares and has not made any purchases. The recent transaction is part of a broader trend observed at WAVE Life Sciences Ltd, where there have been 7 insider sells and 4 insider buys over the past year.
Shares of WAVE Life Sciences Ltd were trading at $14.32 on the day of the transaction, giving the company a market cap of approximately $2.08 billion. According to the GF Value, the stock is currently significantly overvalued, with a price-to-GF-Value ratio of 3.62. The GF Value of $3.96 is based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates.
This insider sale might interest investors tracking insider behaviors as an indicator of potential stock performance, particularly in the context of the company's valuation and market trends.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
